{"id":59,"date":"2016-02-12T00:15:44","date_gmt":"2016-02-11T23:15:44","guid":{"rendered":"https:\/\/www.purkynuvfond.cz\/?page_id=59"},"modified":"2020-03-25T16:06:47","modified_gmt":"2020-03-25T15:06:47","slug":"rozhovor-s-doc-mudr-mgr-markem-mrazem-ph-d","status":"publish","type":"page","link":"https:\/\/www.purkynuvfond.cz\/vitezne-prace\/rozhovor-s-doc-mudr-mgr-markem-mrazem-ph-d\/","title":{"rendered":"Ro\u010dn\u00edk 2015"},"content":{"rendered":"<figure><span style=\"font-size: 20px;\"><strong>Rozhovor s doc. MUDr. Mgr. Markem Mr\u00e1zem, Ph.D.\u00a0<\/strong><\/span><\/figure>\n<figure><span style=\"font-size: 20px;\"><strong>V\u00edt\u011bz Ocen\u011bn\u00ed publikace v \u010dasopise s nejvy\u0161\u0161\u00edm impact factorem za rok 2015 <\/strong><\/span><\/figure>\n<figure><\/figure>\n<figure><img loading=\"lazy\" decoding=\"async\" class=\"alignright size-medium wp-image-200\" src=\"http:\/\/purkynuvfond.cz\/wp-content\/uploads\/2016\/02\/dr.mraz-2-200x300.jpg\" alt=\"Dr Mraz 2\" width=\"200\" height=\"300\" srcset=\"https:\/\/www.purkynuvfond.cz\/wp-content\/uploads\/2016\/02\/dr.mraz-2-200x300.jpg 200w, https:\/\/www.purkynuvfond.cz\/wp-content\/uploads\/2016\/02\/dr.mraz-2-768x1154.jpg 768w, https:\/\/www.purkynuvfond.cz\/wp-content\/uploads\/2016\/02\/dr.mraz-2-682x1024.jpg 682w, https:\/\/www.purkynuvfond.cz\/wp-content\/uploads\/2016\/02\/dr.mraz-2-60x90.jpg 60w, https:\/\/www.purkynuvfond.cz\/wp-content\/uploads\/2016\/02\/dr.mraz-2.jpg 984w\" sizes=\"auto, (max-width: 200px) 100vw, 200px\" \/><\/figure>\n<p><strong>Ocen\u011bn\u00ed Purky\u0148ova nada\u010dn\u00edho fondu jste z\u00edskal za pr\u00e1ci o B bun\u011b\u010dn\u00fdch n\u00e1dorech. M\u016f\u017eete pros\u00edm dan\u00fd v\u00fdzkum kr\u00e1tce objasnit?<br \/>\n<\/strong>V\u011bnujeme se studiu B bun\u011b\u010dn\u00fdch leuk\u00e9mi\u00ed a lymfom\u016f, co\u017e jsou onemocn\u011bn\u00ed, kter\u00e1 vznikaj\u00ed z\u00a0B lymfocyt\u016f, co\u017e jsou bu\u0148ky, kter\u00e9 za norm\u00e1ln\u00edch okolnost\u00ed chr\u00e1n\u00ed t\u011blo proti infekci t\u00edm, \u017ee produkuj\u00ed protil\u00e1tky. N\u011bkdy se ale m\u016f\u017ee st\u00e1t, \u017ee dojde k malign\u00ed transformaci B lymfocyt\u016f a vznikne chronick\u00e1 lymfocyt\u00e1rn\u00ed leuk\u00e9mie nebo B bun\u011b\u010dn\u00fd lymfom. Je zaj\u00edmav\u00e9, \u017ee ke vzniku t\u011bchto n\u00e1doru \u010dasto vede poru\u0161en\u00ed molekul\u00e1rn\u00ed dr\u00e1hy, kter\u00e1 m\u00e1 pr\u00e1v\u011b na starosti produkci protil\u00e1tek (tzv. BCR signalizace). V\u00a0z\u00e1sad\u011b zat\u00edm nen\u00ed jasn\u00e9, jak k\u00a0n\u011bmu u v\u011bt\u0161iny p\u0159\u00edpad\u016f p\u0159esn\u011b doch\u00e1z\u00ed. V\u00a0posledn\u00edch dvou letech jsme objasnili v\u00fdznam nek\u00f3duj\u00edc\u00edch RNA tzv. miRNA v (de)regulaci signalizace p\u0159es B bun\u011b\u010dn\u00fd receptor (BCR) a zasadili tato pozorov\u00e1n\u00ed do kontextu zn\u00e1m\u00e9 biologie B bun\u011b\u010dn\u00fdch malignit, za co\u017e jsme z\u00edskali ocen\u011bn\u00ed Purky\u0148ova nada\u010dn\u00edho fondu, kter\u00e9ho si velmi v\u00e1\u017e\u00edm.<\/p>\n<p><strong>Ve St\u0159edoevropsk\u00e9m v\u00fdzkumn\u00e9m institutu (CEITEC MU) p\u016fsob\u00edte jako vedouc\u00ed v\u00fdzkumn\u00e9 skupiny Mikroprost\u0159ed\u00ed imunitn\u00edch bun\u011bk \u2013 na jak\u00e9m projektu se sv\u00fdm t\u00fdmem pracujete?<br \/>\n<\/strong>Zaj\u00edm\u00e1 n\u00e1s, jak interakce v\u00a0mikroprost\u0159ed\u00ed imunitn\u00edch org\u00e1n\u016f ovliv\u0148uj\u00ed biologii a terapeutickou rezistenci u chronick\u00e9 lymfatick\u00e9 leuk\u00e9mie, B bun\u011b\u010dn\u00fdch lymfom\u016f a dal\u0161\u00edch malignit. V\u00a0posledn\u00ed dob\u011b se ukazuje, \u017ee i velice agresivn\u00ed typy hematologick\u00fdch malignit jsou st\u00e1le z\u00e1visl\u00e9 na interakc\u00edch v\u00a0mikroprost\u0159ed\u00ed a tyto interakce jsou c\u00edlem nejnov\u011bj\u0161\u00edch l\u00e9\u010div, jako jsou t\u0159eba inhibitory BCR signaliza\u010dn\u00ed dr\u00e1hy. Pr\u00e1v\u011b mechanismy aktivace BCR dr\u00e1hy a souvislost s\u00a0adhez\u00ed a migrac\u00ed bun\u011bk studujeme v\u00a0na\u0161\u00ed laborato\u0159i. Studujeme, jak jsou tyto dr\u00e1hy regulov\u00e1ny a jak to zohlednit terapeuticky. V\u00a0ned\u00e1vn\u00e9 dob\u011b jsme nap\u0159\u00edklad s\u00a0moj\u00ed doktorandkou popsali jak je regulov\u00e1na hladina n\u011bkter\u00fdch povrchov\u00fdch molekul leukemick\u00fdch B lymfocyt\u016f pr\u00e1v\u011b v\u00a0kontextu mikroprost\u0159ed\u00ed a jak to vyu\u017e\u00edt terapeuticky (Pavlasova et al, Blood, 2016). Neodd\u011blitelnou sou\u010d\u00e1st\u00ed na\u0161\u00ed pr\u00e1ce je \u00fazk\u00e1 spolupr\u00e1ce s\u00a0l\u00e9ka\u0159i na Intern\u00ed hematologick\u00e9 a onkologick\u00e9 klinice FN Brno, kte\u0159\u00ed maj\u00ed v\u00a0p\u00e9\u010di pacienty a s\u00a0nimi\u017e se sna\u017e\u00edme, aby tito z\u00a0na\u0161eho v\u00fdzkumu pokud mo\u017eno profitovali.<\/p>\n<p><strong>Tento v\u00fdzkumn\u00fd t\u00fdm budujete teprve od za\u010d\u00e1tku roku, jak se v\u00e1m da\u0159\u00ed a jak\u00e9 m\u00e1te s\u00a0t\u00fdmem dal\u0161\u00ed pl\u00e1ny? <\/strong><br \/>\nOd za\u010d\u00e1tku roku jsem vedouc\u00edm v\u00fdzkumn\u00e9 skupiny v\u00a0CEITECu Masarykovy univerzity. M\u016fj t\u00fdm je relativn\u011b mal\u00fd a sna\u017e\u00edme se te\u010f p\u0159edev\u0161\u00edm z\u00edskat dostate\u010dnou finan\u010dn\u00ed podporu pro jeho stabilizaci. R\u00e1di bychom studovali interakce v\u00a0mikroprost\u0159ed\u00ed imunitn\u00edch bun\u011bk, nebo\u0165 v\u011b\u0159\u00edme, \u017ee zde le\u017e\u00ed cesta k\u00a0jejich c\u00edlen\u00e9 l\u00e9\u010db\u011b. Nejnov\u011bj\u0161\u00ed l\u00e9ky v\u00a0terapii B bun\u011b\u010dn\u00fdch leuk\u00e9mi\u00ed a lymfom\u016f vyu\u017e\u00edvaj\u00ed c\u00edlen\u00e9 inhibice BCR signalizace, co\u017e je velmi \u00fa\u010dinn\u00e9, ale st\u00e1le to nevede k\u00a0vyl\u00e9\u010den\u00ed pacient\u016f a mnoho t\u011bchto chorob z\u016fst\u00e1v\u00e1 nevyl\u00e9\u010diteln\u00fdch. R\u00e1di bychom na\u0161li vhodn\u00fd \u201el\u00e9k\u201c do kombinace s\u00a0ji\u017e velmi \u00fa\u010dinn\u00fdmi\u00a0BCR inhibitory. T\u00edm snad alespo\u0148 u \u010d\u00e1sti pacient\u016f dok\u00e1\u017eeme chorobu trvale kontrolovat nebo dokonce vyl\u00e9\u010dit. P\u0159\u00e1l bych si, aby na tomto v\u00fdzkumu \u00fazce spolupracoval\u00a0CEITEC MU s Intern\u00ed hematologickou a onkologickou klinikou FN Brno a dal\u0161\u00edmi pracovi\u0161ti v\u00a0\u010cR a ve sv\u011bt\u011b.<\/p>\n<figure><img loading=\"lazy\" decoding=\"async\" class=\"alignright size-medium wp-image-199\" src=\"http:\/\/purkynuvfond.cz\/wp-content\/uploads\/2016\/02\/dr.mraz_-201x300.jpg\" alt=\"Dr Mraz\" width=\"201\" height=\"300\" srcset=\"https:\/\/www.purkynuvfond.cz\/wp-content\/uploads\/2016\/02\/dr.mraz_-201x300.jpg 201w, https:\/\/www.purkynuvfond.cz\/wp-content\/uploads\/2016\/02\/dr.mraz_-768x1148.jpg 768w, https:\/\/www.purkynuvfond.cz\/wp-content\/uploads\/2016\/02\/dr.mraz_-685x1024.jpg 685w, https:\/\/www.purkynuvfond.cz\/wp-content\/uploads\/2016\/02\/dr.mraz_-60x90.jpg 60w, https:\/\/www.purkynuvfond.cz\/wp-content\/uploads\/2016\/02\/dr.mraz_.jpg 1370w\" sizes=\"auto, (max-width: 201px) 100vw, 201px\" \/><\/figure>\n<p><strong>Str\u00e1vil jste t\u00e9m\u011b\u0159 3 roky v\u00a0San Diegu na v\u00fdzkumu l\u00e9\u010dby leuk\u00e9mie. O co konkr\u00e9tn\u011b se jednalo? <\/strong><br \/>\nPracoval jsem s\u00a0profesorem Thomasem Kippsem na v\u00fdzkumu signalizace p\u0159es B bun\u011b\u010dn\u00fd receptor a p\u0159edev\u0161\u00edm na \u00faloze nek\u00f3duj\u00edc\u00edch RNA v\u00a0tomto procesu. Tento v\u00fdzkum vedl k\u00a0n\u011bkolika neo\u010dek\u00e1van\u00fdm objev\u016fm a z\u00e1rove\u0148 otev\u0159el mnoho ot\u00e1zek o biologii B bun\u011b\u010dn\u00fdch malignit.<\/p>\n<p><strong>Jak tato zku\u0161enost ovlivnila Va\u0161i dal\u0161\u00ed profesn\u00ed dr\u00e1hu?<\/strong><br \/>\nS\u00a0univerzitou v\u00a0San Diegu a dal\u0161\u00edmi pracovi\u0161ti\u00a0 v\u00a0USA (Mayo Clinic, Harvard) velmi \u00fazce spolupracujeme a z\u00e1rove\u0148 se sna\u017e\u00edme jim v\u011bdecky \u201ekonkurovat\u201c. Pr\u00e1ce v\u00a0USA &#8211; p\u016fsobil jsem krom\u011b San Diega i na Mayo Clinic &#8211; pro m\u011b byla nenahraditelnou a neocenitelnou zku\u0161enost\u00ed a z\u00e1rove\u0148 jsem r\u00e1d, \u017ee jsem dostal mo\u017enost vr\u00e1tit se do \u010cesk\u00e9 republiky. Do USA jezd\u00edm ka\u017ed\u00fd rok na n\u011bkolik t\u00fddn\u016f designovat spole\u010dn\u00e9 projekty a klinick\u00e9 studie.<\/p>\n<p><strong>Pod\u00edv\u00e1m-li se na V\u00e1\u0161 \u017eivotopis, m\u00e1m dojem, \u017ee jste m\u011bl velmi brzy jasno, \u010demu se chcete v\u011bnovat. Je to spr\u00e1vn\u00fd dojem nebo sehr\u00e1la ve Va\u0161em \u017eivot\u011b roli i n\u00e1hoda? <\/strong><br \/>\nM\u011bl jsem neuv\u011b\u0159iteln\u00e9 \u0161t\u011bst\u00ed, \u017ee jsem jako student potkal ve Fakultn\u00ed nemocnici Brno profesora Ji\u0159\u00edho Mayera a profesorku \u0160\u00e1rku Posp\u00ed\u0161ilovou, kte\u0159\u00ed se stali m\u00fdmi mentory a s\u00a0nimi\u017e v\u00a0Brn\u011b spolupracuji. V\u00a0dob\u011b, kdy jsem studoval medic\u00ednu nebylo \u00fapln\u011b obvykl\u00e9, aby student cht\u011bl pracovat v\u00a0laborato\u0159i nebo dostal mo\u017enost se pod\u00edvat na velkou v\u011bdeckou konferenci v\u00a0USA. J\u00e1 jsem d\u00edky t\u011bmto lidem m\u011bl mo\u017enost oboj\u00edho a to definitivn\u011b rozhodlo, \u017ee se budu v\u011bnovat onkologii. Oba jsou pro m\u011b vzorem a na\u0161e vz\u00e1jemn\u00e1 interakce je to co m\u011b z\u00a0velk\u00e9 \u010d\u00e1sti p\u0159ivedlo z\u00a0USA zp\u011bt do Brna.<\/p>\n<p><strong>Vedete v\u00fdzkumn\u00fd t\u00fdm na \u0161pi\u010dkov\u00e9m v\u011bdeck\u00e9m pracovi\u0161ti (CEITEC MU), spolupracujete s\u00a0Fakultn\u00ed nemocnic\u00ed Brno, v\u011bnujete se publika\u010dn\u00ed \u010dinnosti, p\u0159edn\u00e1\u0161\u00edte. M\u00e1te n\u011bjak\u00fd voln\u00fd \u010das i pro sebe? <\/strong><br \/>\nSna\u017e\u00edm se \u201evydob\u00fdt\u201c si \u010das pro odpo\u010dinek, co\u017e je ide\u00e1ln\u011b n\u011bjak\u00e1 cesta do hor. I kdy\u017e zdaleka ne v\u017edy se to da\u0159\u00ed.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Rozhovor s doc. MUDr. Mgr. Markem Mr\u00e1zem, Ph.D.\u00a0 V\u00edt\u011bz Ocen\u011bn\u00ed publikace v \u010dasopise s nejvy\u0161\u0161\u00edm impact factorem za rok 2015 Ocen\u011bn\u00ed Purky\u0148ova nada\u010dn\u00edho fondu jste z\u00edskal za pr\u00e1ci o B bun\u011b\u010dn\u00fdch n\u00e1dorech. M\u016f\u017eete pros\u00edm dan\u00fd v\u00fdzkum kr\u00e1tce objasnit? V\u011bnujeme se studiu B bun\u011b\u010dn\u00fdch leuk\u00e9mi\u00ed a lymfom\u016f, co\u017e jsou onemocn\u011bn\u00ed, kter\u00e1 vznikaj\u00ed z\u00a0B lymfocyt\u016f, co\u017e jsou [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":49,"menu_order":65,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-59","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.purkynuvfond.cz\/api\/wp\/v2\/pages\/59","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.purkynuvfond.cz\/api\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.purkynuvfond.cz\/api\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.purkynuvfond.cz\/api\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.purkynuvfond.cz\/api\/wp\/v2\/comments?post=59"}],"version-history":[{"count":13,"href":"https:\/\/www.purkynuvfond.cz\/api\/wp\/v2\/pages\/59\/revisions"}],"predecessor-version":[{"id":1734,"href":"https:\/\/www.purkynuvfond.cz\/api\/wp\/v2\/pages\/59\/revisions\/1734"}],"up":[{"embeddable":true,"href":"https:\/\/www.purkynuvfond.cz\/api\/wp\/v2\/pages\/49"}],"wp:attachment":[{"href":"https:\/\/www.purkynuvfond.cz\/api\/wp\/v2\/media?parent=59"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}